Impact BioMedical, Inc. (IBO)
3.60
-0.20
(-5.26%)
USD |
NYAM |
Oct 23, 16:00
3.55
-0.05
(-1.39%)
After-Hours: 20:00
Impact BioMedical Total Return Level : 3.60 for Oct. 23, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 23, 2026 | 3.60 |
| October 22, 2026 | 3.80 |
| October 21, 2026 | 4.02 |
| October 20, 2026 | 3.268 |
| October 19, 2026 | 3.06 |
| October 16, 2026 | 2.68 |
| October 15, 2026 | 3.158 |
| October 14, 2026 | 3.403 |
| October 13, 2026 | 3.98 |
| October 12, 2026 | 4.03 |
| October 09, 2026 | 4.25 |
| October 08, 2026 | 4.11 |
| October 07, 2026 | 4.48 |
| October 06, 2026 | 4.68 |
| October 05, 2026 | 4.84 |
| October 02, 2026 | 5.320 |
| October 01, 2026 | 5.43 |
| September 30, 2026 | 5.60 |
| September 29, 2026 | 5.60 |
| September 28, 2026 | 5.61 |
| September 25, 2026 | 5.69 |
| September 24, 2026 | 5.65 |
| September 23, 2026 | 6.63 |
| September 22, 2026 | 6.658 |
| September 21, 2026 | 7.013 |
| Date | Value |
|---|---|
| September 18, 2026 | 7.446 |
| September 17, 2026 | 7.211 |
| September 16, 2026 | 6.285 |
| September 15, 2026 | 6.676 |
| September 14, 2026 | 6.109 |
| September 11, 2026 | 5.808 |
| September 10, 2026 | 5.565 |
| September 09, 2026 | 6.230 |
| September 08, 2026 | 6.31 |
| September 04, 2026 | 6.815 |
| September 03, 2026 | 6.058 |
| September 02, 2026 | 6.184 |
| September 01, 2026 | 5.78 |
| August 31, 2026 | 5.820 |
| August 28, 2026 | 5.600 |
| August 27, 2026 | 5.565 |
| August 26, 2026 | 5.554 |
| August 25, 2026 | 5.808 |
| August 24, 2026 | 5.717 |
| August 21, 2026 | 6.058 |
| August 20, 2026 | 5.670 |
| August 19, 2026 | 5.467 |
| August 18, 2026 | 5.931 |
| August 17, 2026 | 6.025 |
| August 14, 2026 | 5.796 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| LENZ Therapeutics, Inc. | 3.361 |
| Enveric Biosciences, Inc. | 1.40 |
| ANI Pharmaceuticals, Inc. | 72.61 |
| Corcept Therapeutics, Inc. | 85.86 |
| Veru, Inc. | 2.619 |